Powder: -20°C for 3 years | In solvent: -80°C for 1 year
FGI-106 is active against Ebola, Rift Valley and Dengue Fever viruses with EC50s of 100 nM, 800 nM and 400-900 nM, respectively. FGI-106 also inhibits non-hemorrhagic fever viruses HCV and HIV-1 with EC50s of 200 nM and 150 nM, respectively. FGI-106 is a potent and broad-spectrum inhibitor with inhibitory activity against multiple viruses.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 2,420.00 | |
50 mg | 10-14 weeks | $ 3,180.00 | |
100 mg | 10-14 weeks | $ 4,300.00 |
Description | FGI-106 is active against Ebola, Rift Valley and Dengue Fever viruses with EC50s of 100 nM, 800 nM and 400-900 nM, respectively. FGI-106 also inhibits non-hemorrhagic fever viruses HCV and HIV-1 with EC50s of 200 nM and 150 nM, respectively. FGI-106 is a potent and broad-spectrum inhibitor with inhibitory activity against multiple viruses. |
Targets&IC50 | Ebola virus:(EC50)100 nM , Dengue Fever virus: 400-900 nM , HIV-1:150 nM , HCV: 200 nM , Rift Valley virus: 800 nM |
In vitro | In cell-based assays, treatment with FGI-106 inhibits viral replication by divergent virus families, including positive and negative-strand RNA viruses.Treatment with 2 μM FGI-106 mediated a 4 log reduction in infectious viral titers relative to matched controls, with an EC90 for inhibition of viral killing of host cells (Vero E6 cells) estimated to be 0.6 μM. |
In vivo | FGI-106 (0.1-5 mg/kg;?intraperitoneal injection;?treatments on days 2 and 5;?C57BL/6 or BALB/c mice) treatment decreases mortality from Zaire EBOV in a dose-dependent manner. |
Molecular Weight | 458.64 |
Formula | C28H38N6 |
CAS No. | 501081-38-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
FGI-106 501081-38-5 Others FGI 106 FGI106 inhibitor inhibit